BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2892832)

  • 1. Effects of neuroleptics on body temperature.
    Dilsaver SC
    J Clin Psychiatry; 1988 Feb; 49(2):78-9. PubMed ID: 2892832
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothermia caused by antipsychotic drugs in a schizophrenic patient.
    Noto T; Hashimoto H; Sugae S; Okamoto K; Nakao J; Kamimura H; Nakajima T
    J Clin Psychiatry; 1987 Feb; 48(2):77-8. PubMed ID: 3804993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluphenazine-induced extrapyramidal side effects in a horse.
    Brashier M
    Vet Clin North Am Equine Pract; 2006 Apr; 22(1):e37-45. PubMed ID: 16627093
    [No Abstract]   [Full Text] [Related]  

  • 5. Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy.
    Chen KC; Yang YK; Chen PS; Yeh TL; Yang MJ
    Psychiatry Clin Neurosci; 2003 Aug; 57(4):369-71. PubMed ID: 12839516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypothermia caused by neuroleptics. 2 case reports and review of the literature].
    Maier U; Aigner JM; Klein HE
    Nervenarzt; 1994 Jul; 65(7):488-91. PubMed ID: 7800095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biperiden (Akineton): effective prophylactic and therapeutic anti-parkinsonian agent.
    Kline NS; Mason BT; Winick L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):838-43. PubMed ID: 4155670
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased extrapyramidal side effects and polypsichopharmacy in family practice outpatients.
    Holt RJ
    Bol Asoc Med P R; 1983 Aug; 75(8):351-2. PubMed ID: 6139115
    [No Abstract]   [Full Text] [Related]  

  • 10. Zotepine-Associated Hypothermia in a Schizophrenic Inpatient.
    Chen TR; Chen YC; Ouyang WC
    J Clin Psychopharmacol; 2017 Jun; 37(3):367-368. PubMed ID: 28277401
    [No Abstract]   [Full Text] [Related]  

  • 11. Lithium and extrapyramidal side effects of neuroleptics.
    Weiden P
    Am J Psychiatry; 1987 Feb; 144(2):264-5. PubMed ID: 2880518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects and complications of neuroleptics (110 hospitalizations in neurology)].
    Destee A; Montagne B; Rousseaux M; Petit H; Warot P
    Lille Med; 1980; 25(6):291-5. PubMed ID: 6105602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic drug action: clinical, biochemical, and pharmacological evidence for site specificity of action.
    Borison RL; Hitri A; Blowers AJ; Diamond BI
    Clin Neuropharmacol; 1983 Jun; 6(2):137-50. PubMed ID: 6133618
    [No Abstract]   [Full Text] [Related]  

  • 15. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL; Kelly MW
    Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The enhanced neuroleptic therapy and malignant syndrome].
    Jiang ZN
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Apr; 16(2):84-6. PubMed ID: 6137330
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluphenazine enanthate induced decompensations.
    Van Putten T; Mutalipassi LR
    Psychosomatics; 1975; 16(1):37-40. PubMed ID: 1178807
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential.
    Arnt J; Christensen AV; Hyttel J
    Neuropharmacology; 1981 Dec; 20(12B):1331-4. PubMed ID: 6119645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Schizophrenia: adverse effects of atypical neuroleptics].
    Bettina Polk B
    Med Monatsschr Pharm; 2003 Feb; 26(2):57-9. PubMed ID: 12619525
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J; Otermin P
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.